£81.99

Drug Development & Rare Pediatric Diseases: Issues, Strategic Plan, & Voucher Program Assessment (Pharmacology-research, Safety Testing and Regulation)

Diseases & Disorders

Price data last checked 37 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£82 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 54 days · 54 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 54 days • 1 price levels

Days at Price

Price Analysis

Most common price: £82 (54 days, 100.0%)

Price range: £82 - £82

Price levels: 1 different prices over 54 days

Description

Over the past few decades, a number of legislative actions have been taken to encourage the development of therapies to treat people affected by rare diseases and to encourage therapies for pediatric patients. During this same time period, the Food and Drug Administration (FDA) has invested substantial effort in support of these same goals. As described in this book, recent legislative actions have prompted new initiatives. Continuing the response to the laws specific requirements and FDAs commitment under PDUFA, this book includes input from the public and FDA and discusses the many complex issues involved in medical product development for people with rare diseases. Following a brief overview of both legislative and FDA efforts over the years to foster development of therapies for these patients, the book summarizes the three days of the public meeting and presents FDAs strategic plan for accelerating the development of the urgently needed therapies for pediatric rare diseases.

Product Specifications

Format: paperback
ASIN: 153610227X
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders
Domain: Amazon UK
Release Date: 01 December 2016
Listed Since: 15 September 2016

Barcode

No barcode data available

Drug Development & Rare Pediatric Diseases: Issues, Strategic Plan, & Voucher Program Assessment (Pharmacology-research, Safety Testing and Regulation)

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Drug Development for Rare Diseases (Chapman & Hall/CRC Biostatistics Series)

Rare Diseases: Challenges and Opportunities for Social Entrepreneurs

Propelling Innovation in New Drugs: Recommendations & Considerations (Pharmacology-Research, Safety Testing and Regulation)

Essentials of Translational Pediatric Drug Development: From Past Needs to Future Opportunities

Social Aspects of Drug Discovery, Development and Commercialization

Orphan Drugs: Understanding the Rare Disease Market and Its Dynamics (Woodhead Publishing Series in Biomedicine)

Global New Drug Development: An Introduction (ULLA Series in Pharmaceutical Sciences)

FDA Regulatory Affairs: Third Edition

Research and Development in the Pharmaceutical Industry

Pediatric Pharmacotherapy: 261 (Handbook of Experimental Pharmacology, 261)

Economics of Drug R&D:Financing, Strategic and Policy Considerations; Price Regulation,Capital Market Imperfections and Strategic R&D Investment Behavior in the Pharmaceutical Industry

Economics of the Pharmaceutical and Medical Device Industry: Supply Chain, Trade and Innovation (Routledge Studies in the Economics of Innovation)

Rational Drug Design: Methods and Protocols: 928 (Methods in Molecular Biology, 928)

Regulatory Affairs in the Pharmaceutical Industry

Global Pharmaceutical Policy: Ensuring Medicines for Tomorrow’s World

Commercialization of BioPharma Products in the USA (BW): A Practical Guide

Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series)